메뉴 건너뛰기




Volumn 2, Issue 3, 1996, Pages 148-155

In vitro and in vivo evaluation of DU6859a, a new fluoroquinolone, among injectable antibacterials tested against clinical isolates

Author keywords

Antibacterial activity; DU6859a; Efficacy; Injectable drug

Indexed keywords


EID: 10644267042     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02351567     Document Type: Article
Times cited : (2)

References (14)
  • 2
    • 0024696043 scopus 로고
    • Bacterial resistance to quinolones: Mechanisms and clinical importance
    • Wolfson JS, Hooper DC. Bacterial resistance to quinolones: mechanisms and clinical importance. Rev Infect Dis 1989;11:S960-S968.
    • (1989) Rev Infect Dis , vol.11
    • Wolfson, J.S.1    Hooper, D.C.2
  • 3
    • 0025029336 scopus 로고
    • Development of quinolone-imipenem cross-resistance in Pseudomonas aeruginosa during exposure to ciprofloxacin
    • Radberg G, Nilsson LE, Svensson S. Development of quinolone-imipenem cross-resistance in Pseudomonas aeruginosa during exposure to ciprofloxacin. Antimicrob Agents Chemother 1990;34:2142-2147.
    • (1990) Antimicrob Agents Chemother , vol.34 , pp. 2142-2147
    • Radberg, G.1    Nilsson, L.E.2    Svensson, S.3
  • 4
    • 0026719282 scopus 로고
    • Antimicrobial activity of DU6859a, a new potent fluoroquinolone, against clinical isolates
    • Sato K, Hoshino K, Tanaka M, Hayakawa I, Osada Y. Antimicrobial activity of DU6859a, a new potent fluoroquinolone, against clinical isolates. Antimicrob Agents Chemother 1992;36:1491-1498.
    • (1992) Antimicrob Agents Chemother , vol.36 , pp. 1491-1498
    • Sato, K.1    Hoshino, K.2    Tanaka, M.3    Hayakawa, I.4    Osada, Y.5
  • 5
    • 0026780231 scopus 로고
    • Photostability and biological activity of fluoroquinolones substituted at the 8 position after UV irradiation
    • Matsumoto M, Kojima K, Nagano H, Matsumoto S, Yokota T. Photostability and biological activity of fluoroquinolones substituted at the 8 position after UV irradiation. Antimicrob Agents Chemother 1992;36:1715-1719.
    • (1992) Antimicrob Agents Chemother , vol.36 , pp. 1715-1719
    • Matsumoto, M.1    Kojima, K.2    Nagano, H.3    Matsumoto, S.4    Yokota, T.5
  • 6
    • 0026563036 scopus 로고
    • Adverse effects of fluoroquinolones
    • Shimada J, Hori S. Adverse effects of fluoroquinolones. Prog Drug Res 1992;38:133-143.
    • (1992) Prog Drug Res , vol.38 , pp. 133-143
    • Shimada, J.1    Hori, S.2
  • 7
    • 0022374762 scopus 로고
    • The fluoroquinolones: Pharmacology, clinical uses, and toxicities in humans
    • Hooper, DC, Wolfson JS. The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans. Antimicrob Agents Chemother 1985;28:716-721.
    • (1985) Antimicrob Agents Chemother , vol.28 , pp. 716-721
    • Hooper, D.C.1    Wolfson, J.S.2
  • 8
    • 0028227016 scopus 로고
    • Comparative pharmacokinetics and safety of ciprofloxacin 400 mg iv thrice daily versus 750 mg po twice daily
    • Sha J, Kaiser LL, Echols R, Heller AH. Comparative pharmacokinetics and safety of ciprofloxacin 400 mg iv thrice daily versus 750 mg po twice daily. J Antimicrob Chemother 1994;33:795-801.
    • (1994) J Antimicrob Chemother , vol.33 , pp. 795-801
    • Sha, J.1    Kaiser, L.L.2    Echols, R.3    Heller, A.H.4
  • 9
    • 0026556709 scopus 로고
    • Fluoroquinolone resistance, an evolving national problem or just a problem for some physicians?
    • Jones RN. Fluoroquinolone resistance, an evolving national problem or just a problem for some physicians? Diagn Microbiol Infect Dis 1992;15:177-179.
    • (1992) Diagn Microbiol Infect Dis , vol.15 , pp. 177-179
    • Jones, R.N.1
  • 10
    • 0002160117 scopus 로고
    • The fluoroquinolones: Clinical and laboratory considerations
    • Wolfson JS, Hooper DC. The fluoroquinolones: clinical and laboratory considerations. Clin Microbiol Rev 1992;14:1-7.
    • (1992) Clin Microbiol Rev , vol.14 , pp. 1-7
    • Wolfson, J.S.1    Hooper, D.C.2
  • 11
    • 34249760938 scopus 로고    scopus 로고
    • Incidence of penicillin-resistant Streptococcus pneumoniae in Japan, 1993-1995
    • Ubukata K, Asahi Y, Okuzumi K, Konno M, the Working Group for Penicillin-Resistant 5. Pneumoniae. Incidence of penicillin-resistant Streptococcus pneumoniae in Japan, 1993-1995. J Infect Chemother 1996;1:177-184.
    • (1996) J Infect Chemother , vol.1 , pp. 177-184
    • Ubukata, K.1    Asahi, Y.2    Okuzumi, K.3    Konno, M.4
  • 13
    • 85030002777 scopus 로고
    • In vitro postantibiotic effect, pharmacokinetics in mice, and in vivo effective regrowth time of a new quinolone, DU6859a
    • Washington DC: American Society for Microbiology, abstr
    • Totsuka K, Shimizu K. In vitro postantibiotic effect, pharmacokinetics in mice, and in vivo effective regrowth time of a new quinolone, DU6859a. In: Program and Abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington DC: American Society for Microbiology, 1993;302 (abstr).
    • (1993) Program and Abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy , vol.302
    • Totsuka, K.1    Shimizu, K.2
  • 14
    • 0029039624 scopus 로고
    • In vitro and in vivo antibacterial activities of BO-2727, a new carbapenem
    • Asahi Y, Miyazaki, S, Yamaguchi K. In vitro and in vivo antibacterial activities of BO-2727, a new carbapenem. Antimicrob Agents Chemother 1995;39:1030-1037.
    • (1995) Antimicrob Agents Chemother , vol.39 , pp. 1030-1037
    • Asahi, Y.1    Miyazaki, S.2    Yamaguchi, K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.